• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.27% Nasdaq Up 2.45%

    Coherus Biosciences, Inc. (CHRS)

    -NasdaqGM
    28.54 Up 1.14(4.16%) Aug 27, 3:59PM EDT
    Add to Portfolio
    Prev Close:27.40
    Open:27.50
    Bid:23.14 x 100
    Ask:N/A
    1y Target Est:7.35
    Beta:1.71
    Next Earnings Date:N/A
    Day's Range:27.06 - 28.61
    52wk Range:12.38 - 38.10
    Volume:274,032
    Avg Vol (3m):324,431
    Market Cap:1.09B
    P/E (ttm):N/A
    EPS (ttm):-5.72
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CHRS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):29.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jan-13) :N/A
    Quarterly EPS Est (Jul-12) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. Its clinical stage pipeline consists of CHS-0214, an etanercept biosimilar candidate, which is in... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback